- Home
- RGCO vs TIL Comparison
RGCO vs TIL Comparison
Compare RGCO & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGCO
- TIL
- Stock Information
- Founded
- RGCO 1912
- TIL 2018
- Country
- RGCO United States
- TIL United States
- Employees
- RGCO N/A
- TIL N/A
- Industry
- RGCO Oil & Gas Production
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- RGCO Utilities
- TIL Health Care
- Exchange
- RGCO Nasdaq
- TIL Nasdaq
- Market Cap
- RGCO 221.2M
- TIL 177.1M
- IPO Year
- RGCO N/A
- TIL 2021
- Fundamental
- Price
- RGCO $22.22
- TIL $21.55
- Analyst Decision
- RGCO
- TIL Buy
- Analyst Count
- RGCO 0
- TIL 6
- Target Price
- RGCO N/A
- TIL $120.50
- AVG Volume (30 Days)
- RGCO 15.7K
- TIL 145.1K
- Earning Date
- RGCO 11-12-2025
- TIL 11-12-2025
- Dividend Yield
- RGCO 3.74%
- TIL N/A
- EPS Growth
- RGCO 5.90
- TIL N/A
- EPS
- RGCO 1.32
- TIL N/A
- Revenue
- RGCO $94,120,500.00
- TIL N/A
- Revenue This Year
- RGCO $14.48
- TIL N/A
- Revenue Next Year
- RGCO $2.11
- TIL N/A
- P/E Ratio
- RGCO $16.77
- TIL N/A
- Revenue Growth
- RGCO 12.04
- TIL N/A
- 52 Week Low
- RGCO $19.06
- TIL $10.80
- 52 Week High
- RGCO $24.20
- TIL $73.69
- Technical
- Relative Strength Index (RSI)
- RGCO 52.60
- TIL 38.52
- Support Level
- RGCO $21.50
- TIL $22.67
- Resistance Level
- RGCO $22.48
- TIL $25.89
- Average True Range (ATR)
- RGCO 0.57
- TIL 2.61
- MACD
- RGCO -0.04
- TIL -0.62
- Stochastic Oscillator
- RGCO 60.00
- TIL 10.46
About RGCO RGC Resources Inc.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.